-
1
-
-
0023884418
-
Improved survival of patients with cancers of the colon and rectum?
-
DOI: 10.1093/jnci/80.8.586
-
Enblad P, Adami HO, Bergstöm R, Glimelius B, Krusemu V, Pahlman L. Improved survival of patients with cancers of the colon and rectum? J Natl Cancer Inst. 1988;80(8):586-91. DOI: 10.1093/jnci/80.8.586
-
(1988)
J Natl Cancer Inst.
, vol.80
, Issue.8
, pp. 586-591
-
-
Enblad, P.1
Adami, H.O.2
Bergstöm, R.3
Glimelius, B.4
Krusemu, V.5
Pahlman, L.6
-
2
-
-
0027234546
-
Is follow-up of colorectal cancer patients worthwhile?
-
DOI: 10.1007/BF02238589
-
Safi F, Link KH, Beger HG. Is follow-up of colorectal cancer patients worthwhile? Dis Colon Rectum. 1993;36(7):636-44. DOI: 10.1007/BF02238589
-
(1993)
Dis Colon Rectum.
, vol.36
, Issue.7
, pp. 636-644
-
-
Safi, F.1
Link, K.H.2
Beger, H.G.3
-
3
-
-
0018348655
-
Tantigen is bound to a host protein in SV40-transformed cells
-
DOI: 10.1038/278261a0
-
Lane DP, Crawford L V. Tantigen is bound to a host protein in SV40-transformed cells. Nature. 1979;278(5701):261-3. DOI: 10.1038/278261a0
-
(1979)
Nature.
, vol.278
, Issue.5701
, pp. 261-263
-
-
Lane, D.P.1
Crawford, L.V.2
-
4
-
-
0025711796
-
Cancer. A deadly inheritance
-
DOI: 10.1038/348681a0
-
Vogelstein B. Cancer. A deadly inheritance. Nature. 1990;348(6303):681-2. DOI: 10.1038/348681a0
-
(1990)
Nature.
, vol.348
, Issue.6303
, pp. 681-682
-
-
Vogelstein, B.1
-
5
-
-
0027109075
-
Cancer. p53, guardian of the genome
-
DOI: 10.1038/358015a0
-
Lane DP. Cancer. p53, guardian of the genome. Nature. 1992;358(6381):15-6. DOI: 10.1038/358015a0
-
(1992)
Nature.
, vol.358
, Issue.6381
, pp. 15-16
-
-
Lane, D.P.1
-
6
-
-
0025248598
-
Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form
-
Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J. 1990;9(5):1595-602.
-
(1990)
EMBO J.
, vol.9
, Issue.5
, pp. 1595-1602
-
-
Gannon, J.V.1
Greaves, R.2
Iggo, R.3
Lane, D.P.4
-
7
-
-
0028568315
-
Cell cycle control and cancer
-
DOI: 10.1126/science.7997877
-
Hartwell LH, Kastan MB. Cell cycle control and cancer. Science. 1994;266(5192):1821-8. DOI: 10.1126/science.7997877
-
(1994)
Science.
, vol.266
, Issue.5192
, pp. 1821-1828
-
-
Hartwell, L.H.1
Kastan, M.B.2
-
8
-
-
0026737950
-
Accumulation of p53 protein correlates with poor prognosis in human lung cancer
-
Quinlan DC, Davidson AG, Summers CL, Warden HE, Doshi HM. Accumulation of p53 protein correlates with poor prognosis in human lung cancer. Cancer Res. 1992;52(17):4828-31.
-
(1992)
Cancer Res.
, vol.52
, Issue.17
, pp. 4828-4831
-
-
Quinlan, D.C.1
Davidson, A.G.2
Summers, C.L.3
Warden, H.E.4
Doshi, H.M.5
-
9
-
-
0028982390
-
p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma
-
DOI: 10.1002/1097-0142(19951001)76:7<1201::AID-CNCR2820760716>3.0.CO;2- L
-
Klemi P J, Pylkkaenen L, Kilholma P, Kurvinen K, Joensuu H. p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma. Cancer. 1995;76(7):1201-8. DOI: 10.1002/1097-0142(19951001)76:7<1201::AID-CNCR2820760716>3.0.CO;2- L
-
(1995)
Cancer.
, vol.76
, Issue.7
, pp. 1201-1208
-
-
Klemi, P.J.1
Pylkkaenen, L.2
Kilholma, P.3
Kurvinen, K.4
Joensuu, H.5
-
10
-
-
0028305095
-
Overexpression of p53 protein in adenocarcinoma of the pancreas
-
DiGuiseppe JA, Hruban RH, Goodman SN, Polak M, van den Berg FM, Allison DC, Cameron JL, Offerhaus GJ. Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol. 1994;101(6):684-8.
-
(1994)
Am J Clin Pathol.
, vol.101
, Issue.6
, pp. 684-688
-
-
DiGuiseppe, J.A.1
Hruban, R.H.2
Goodman, S.N.3
Polak, M.4
van den Berg, F.M.5
Allison, D.C.6
Cameron, J.L.7
Offerhaus, G.J.8
-
11
-
-
0028346609
-
The prognostic significance of the accumulation of p53 tumor-suppressor gene protein in gastric adenocarcinoma
-
Joypaul BV, Hopewood D, Newman EL, Qureshi S, Grant A, Ogston SA, Lane DP, Cuschieri A. The prognostic significance of the accumulation of p53 tumor-suppressor gene protein in gastric adenocarcinoma. Br J Cancer. 1994;69(5):943-6.
-
(1994)
Br J Cancer.
, vol.69
, Issue.5
, pp. 943-946
-
-
Joypaul, B.V.1
Hopewood, D.2
Newman, E.L.3
Qureshi, S.4
Grant, A.5
Ogston, S.A.6
Lane, D.P.7
Cuschieri, A.8
-
12
-
-
0028895227
-
Nuclear p53 immunoreactivity in papillary thyroid cancers is associated with two established indicators of poor prognosis
-
DOI: 10.1006/exmp.1995.1006
-
Gerasimov G, Bronstein M, Troshina K, Alexandrova G, Dedov I, Jennings T, Kallakury BV, Izquierdo R, Boguniewicz A, Figge H, et al. Nuclear p53 immunoreactivity in papillary thyroid cancers is associated with two established indicators of poor prognosis. Exp Mol Pathol. 1995;62(1):52-62. DOI: 10.1006/exmp.1995.1006
-
(1995)
Exp Mol Pathol.
, vol.62
, Issue.1
, pp. 52-62
-
-
Gerasimov, G.1
Bronstein, M.2
Troshina, K.3
Alexandrova, G.4
Dedov, I.5
Jennings, T.6
Kallakury, B.V.7
Izquierdo, R.8
Boguniewicz, A.9
Figge, H.10
-
13
-
-
0029073858
-
Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols
-
Borg A, Lennerstand J, Stenmark-Askmalm M, Fernö M, Brisfors A, Ohrvik A, Stål O, Killander D, Lane D, Brundell J. Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosols. Br J Cancer. 1995;71(5):1013-7.
-
(1995)
Br J Cancer.
, vol.71
, Issue.5
, pp. 1013-1017
-
-
Borg, A.1
Lennerstand, J.2
Stenmark-Askmalm, M.3
Fernö, M.4
Brisfors, A.5
Ohrvik, A.6
Stål, O.7
Killander, D.8
Lane, D.9
Brundell, J.10
-
14
-
-
0030013978
-
Prognostic significance of TP53 accumulation in human primary breast cancer: Comparison between a rapid quantitative immunoassay and SSCP analysis
-
DOI: 10.1002/(SICI)1097-0215(19960422)69:2<125::AID-IJC10>3.0.CO;2-8
-
De Witte HH, Foekens JA, Lennerstand J, Smid M, Look MP, Klijn JG, Benraad TJ, Berns EM. Prognostic significance of TP53 accumulation in human primary breast cancer: Comparison between a rapid quantitative immunoassay and SSCP analysis. Int J Cancer. 1996;69(2):125-30. DOI: 10.1002/(SICI)1097-0215(19960422)69:2<125::AID-IJC10>3.0.CO;2-8
-
(1996)
Int J Cancer.
, vol.69
, Issue.2
, pp. 125-130
-
-
De Witte, H.H.1
Foekens, J.A.2
Lennerstand, J.3
Smid, M.4
Look, M.P.5
Klijn, J.G.6
Benraad, T.J.7
Berns, E.M.8
-
15
-
-
0033389842
-
Cytosolic p53 protein and serum p53 autoantibody evaluation in breast cancer. Comparison with prognostic factors
-
Dalifard I, Daver A, Larra F. Cytosolic p53 protein and serum p53 autoantibody evaluation in breast cancer. Comparison with prognostic factors. Anticancer Res. 1999;19(6B):5015-22.
-
(1999)
Anticancer Res.
, vol.19
, Issue.6 B
, pp. 5015-5022
-
-
Dalifard, I.1
Daver, A.2
Larra, F.3
-
16
-
-
0034029990
-
P53 determination alongside classical prognostic factors in nodenegative breast cancer: An evaluation at more than 10-year follow-up
-
DOI: 10.1023/A:1008359722254
-
Ferrero JM, Ramaioli A, Formento JL, Francoual M, Etienne MC, Peyrottes I, Ettore F, Leblanc-Talent P, Namer M, Milano G. P53 determination alongside classical prognostic factors in nodenegative breast cancer: an evaluation at more than 10-year follow-up. Ann Oncol. 2000;11(4):393-7. DOI: 10.1023/A:1008359722254
-
(2000)
Ann Oncol.
, vol.11
, Issue.4
, pp. 393-397
-
-
Ferrero, J.M.1
Ramaioli, A.2
Formento, J.L.3
Francoual, M.4
Etienne, M.C.5
Peyrottes, I.6
Ettore, F.7
Leblanc-Talent, P.8
Namer, M.9
Milano, G.10
-
17
-
-
0029949185
-
Prognostic significance of p53 expression, chromosome 17copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II)
-
DOI: 10.3109/00365529609006769
-
Baretton GB, Vogt M, Diebold J, Schneiderbanger K, Schmidt M, Löhrs U. Prognostic significance of p53 expression, chromosome 17copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II). Scand J Gastroenterol. 1996;31(5):481-9. DOI: 10.3109/00365529609006769
-
(1996)
Scand J Gastroenterol.
, vol.31
, Issue.5
, pp. 481-489
-
-
Baretton, G.B.1
Vogt, M.2
Diebold, J.3
Schneiderbanger, K.4
Schmidt, M.5
Löhrs, U.6
-
18
-
-
4243343244
-
p53 and RB1 gene proteins are not prognostic factors in colorectal cancer
-
Poller DN, Baxter KJ, Shepherd NA. p53 and RB1 gene proteins are not prognostic factors in colorectal cancer. J Pathol. 1995;175:103.
-
(1995)
J Pathol.
, vol.175
, pp. 103
-
-
Poller, D.N.1
Baxter, K.J.2
Shepherd, N.A.3
-
19
-
-
0030018164
-
Immunohistochemical factors influencing growth speed and development of colorectal cancer
-
Matsui T, Yao K, Yao T, Yamada Y, Iwashita A, Furukawa K. Immunohistochemical factors influencing growth speed and development of colorectal cancer. Nippon Daicho Komonbyo Gakkai Zasshi. 1996;49:455-62.
-
(1996)
Nippon Daicho Komonbyo Gakkai Zasshi.
, vol.49
, pp. 455-462
-
-
Matsui, T.1
Yao, K.2
Yao, T.3
Yamada, Y.4
Iwashita, A.5
Furukawa, K.6
-
20
-
-
0030035991
-
Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas
-
Smith DR, Ji CY, Goh HS. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer. 1996;74(2):216-23.
-
(1996)
Br J Cancer.
, vol.74
, Issue.2
, pp. 216-223
-
-
Smith, D.R.1
Ji, C.Y.2
Goh, H.S.3
-
21
-
-
77951938523
-
Prognostic role of betacatenin and p53 expression in the metastatic progression of sporadic colorectal cancer
-
DOI: 10.1016/j.humpath.2009.09.019 [Epub ahead of print]
-
Pancione M, Forte N, Fucci A, Sabatino L, Febbraro A, Di Blasi A, Daniele B, Parente D, Colantuoni V. Prognostic role of betacatenin and p53 expression in the metastatic progression of sporadic colorectal cancer. Hum Pathol. 2010;41(6):867-76. DOI: 10.1016/j.humpath.2009.09.019 [Epub ahead of print]
-
(2010)
Hum Pathol.
, vol.41
, Issue.6
, pp. 867-876
-
-
Pancione, M.1
Forte, N.2
Fucci, A.3
Sabatino, L.4
Febbraro, A.5
Di Blasi, A.6
Daniele, B.7
Parente, D.8
Colantuoni, V.9
-
22
-
-
0027170898
-
p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance
-
Yamaguchi A, Nakagawara G, Kurosaka Y, Nishimura G, Yonemura Y, Miyazaki I. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance. Br J Cancer. 1993;68(2):399-402.
-
(1993)
Br J Cancer.
, vol.68
, Issue.2
, pp. 399-402
-
-
Yamaguchi, A.1
Nakagawara, G.2
Kurosaka, Y.3
Nishimura, G.4
Yonemura, Y.5
Miyazaki, I.6
-
23
-
-
0029957381
-
Interobserver variation of p53 immunohistochemistry-an assessment of a practical problem and comparison with other studies
-
Kay EW, Barry Walsh CJ, Wheelan D, O'Grady A, Leader MB. Interobserver variation of p53 immunohistochemistry-an assessment of a practical problem and comparison with other studies. Br J Biomed Sci. 1996;53(2):101-7.
-
(1996)
Br J Biomed Sci.
, vol.53
, Issue.2
, pp. 101-107
-
-
Kay, E.W.1
Barry Walsh, C.J.2
Wheelan, D.3
O'Grady, A.4
Leader, M.B.5
-
24
-
-
0028286988
-
Cytoplasmatic accumulation of p53 protein: An independent prognostic indicator of colorectal adenocarcinomas
-
DOI: 10.1093/jnci/86.9.681
-
Bosari S, Viale G, Bossi P, Maggioni M, Coggi G, Murray JJ, Lee AK. Cytoplasmatic accumulation of p53 protein: an independent prognostic indicator of colorectal adenocarcinomas. J Natl Cancer Inst. 1994;86(9):681-7. DOI: 10.1093/jnci/86.9.681
-
(1994)
J Natl Cancer Inst.
, vol.86
, Issue.9
, pp. 681-687
-
-
Bosari, S.1
Viale, G.2
Bossi, P.3
Maggioni, M.4
Coggi, G.5
Murray, J.J.6
Lee, A.K.7
-
25
-
-
0030000199
-
Prognostic significance of cytoplasmatic p53 overexpression in colorectal cancer. An immunohistochemical analysis
-
DOI: 10.1016/0959-8049(95)00625-7
-
Flamini G, Curigliano G, Ratto C, Astone A, Ferretti G, Nucera P. Prognostic significance of cytoplasmatic p53 overexpression in colorectal cancer. An immunohistochemical analysis. Eur J Cancer. 1996;32(5):802-6. DOI: 10.1016/0959-8049(95)00625-7
-
(1996)
Eur J Cancer.
, vol.32
, Issue.5
, pp. 802-806
-
-
Flamini, G.1
Curigliano, G.2
Ratto, C.3
Astone, A.4
Ferretti, G.5
Nucera, P.6
-
26
-
-
0026453217
-
Prognostic significance of cytoplasmatic p53 oncoprotein in colorectal adenocarcinoma
-
DOI: 10.1016/0140-6736(92)92558-W
-
Sun XF, Carstensen JM, Zhang A, Stal O, Wingren S, Hatschek T, Nordenskjöld B. Prognostic significance of cytoplasmatic p53 oncoprotein in colorectal adenocarcinoma. Lancet. 1992;340(8832):1369-73. DOI: 10.1016/0140-6736(92)92558-W
-
(1992)
Lancet.
, vol.340
, Issue.8832
, pp. 1369-1373
-
-
Sun, X.F.1
Carstensen, J.M.2
Zhang, A.3
Stal, O.4
Wingren, S.5
Hatschek, T.6
Nordenskjöld, B.7
-
27
-
-
0026578054
-
p53 in tumor pathology: Can we trust immunochemistry?
-
DOI: 10.1002/path.1711660402
-
Wynford-Thomas D. p53 in tumor pathology: Can we trust immunochemistry? J Pathol. 1992;166(4):329-30. DOI: 10.1002/path.1711660402
-
(1992)
J Pathol.
, vol.166
, Issue.4
, pp. 329-330
-
-
Wynford-Thomas, D.1
-
28
-
-
41949092935
-
Anti-p53 autoantibody in colorectal cancer: Prognostic significance in long-term follow-up
-
DOI: 10.1007/s00384-008-0458-4
-
Suppiah A, Alabi A, Madden L, Hartley JE, Monson JR, Greenman J. Anti-p53 autoantibody in colorectal cancer: prognostic significance in long-term follow-up. Int J Colorectal Dis. 2008;23(6):595-600. DOI: 10.1007/s00384-008-0458-4
-
(2008)
Int J Colorectal Dis.
, vol.23
, Issue.6
, pp. 595-600
-
-
Suppiah, A.1
Alabi, A.2
Madden, L.3
Hartley, J.E.4
Monson, J.R.5
Greenman, J.6
-
29
-
-
61449236552
-
P53 and EGFR expression in colorectal cancer: A reappraisal of 'old' tissue markers in patients with long follow-up
-
Theodoropoulos GE, Karafoka E, Papailiou JG, Stamopoulos P, Zambirinis CP, Bramis K, Panoussopoulos SG, Leandros E, Bramis J. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up. Anticancer Res. 2009;29(2):785-91.
-
(2009)
Anticancer Res.
, vol.29
, Issue.2
, pp. 785-791
-
-
Theodoropoulos, G.E.1
Karafoka, E.2
Papailiou, J.G.3
Stamopoulos, P.4
Zambirinis, C.P.5
Bramis, K.6
Panoussopoulos, S.G.7
Leandros, E.8
Bramis, J.9
-
30
-
-
34249881055
-
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use
-
DOI: 10.1016/j.ejca.2007. 03.021
-
Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, Lamerz R, Peltomaki P, Sturgeon C, Topolcan O. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007;43(9):1348-60. DOI: 10.1016/j.ejca.2007. 03.021
-
(2007)
Eur J Cancer.
, vol.43
, Issue.9
, pp. 1348-1360
-
-
Duffy, M.J.1
van Dalen, A.2
Haglund, C.3
Hansson, L.4
Holinski-Feder, E.5
Klapdor, R.6
Lamerz, R.7
Peltomaki, P.8
Sturgeon, C.9
Topolcan, O.10
|